TauRx Chairman Claude Wischik On Waging A Battle Against Alzheimer’s Disease His Way: An Interview With PharmAsia News (Part 2 of 2)

Claude Wischik has spent more than a decade working on a drug that would inhibit the aggregation of tau tangles in the brain, and says his work has put the Singapore-based company TauRx Pharmaceuticals Ltd. onto a path that could produce the world’s best-selling drug, surpassing Pfizer Inc.’s Lipitor (atorvastatin).